Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M207551200 on September 23, 2002

J. Biol. Chem., Vol. 277, Issue 51, 49911-49920, December 20, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
277/51/49911    most recent
M207551200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willcocks, J. P.
Right arrow Articles by Clarke, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willcocks, J. P.
Right arrow Articles by Clarke, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Simultaneous Determination of Low Free Mg2+ and pH in Human Sickle Cells using 31P NMR Spectroscopy*,

James P. WillcocksDagger, Peter J. Mulquiney§, J. Clive Ellory, Richard L. Veech||, George K. Radda, and Kieran Clarke**

From the Departments of Biochemistry and  Physiology, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom, and the || National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland 20852

Received for publication, July 26, 2002, and in revised form, September 11, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The concentrations of free magnesium, [Mg2+]free, [H+], and [ATP] are important in the dehydration of red blood cells from patients with sickle cell anemia, but they are not easily measured. Consequently, we have developed a rapid, noninvasive NMR spectroscopic method using the phosphorus chemical shifts of ATP and 2,3-diphosphoglycerate (DPG) to determine [Mg2+]free and pHi simultaneously in fully oxygenated whole blood. The method employs theoretical equations expressing the observed chemical shift as a function of pH, K+, and [Mg2+]free, over a pH range of 5.75-8.5 and [Mg2+]free range 0-5 mM. The equations were adjusted to allow for the binding of hemoglobin to ATP and DPG, which required knowledge of the intracellular concentrations of ATP, DPG, K+, and hemoglobin. Normal oxygenated whole blood (n = 33) had a pHi of 7.20 ± 0.02, a [Mg2+]free of 0.41 ± 0.03 mM, and [DPG] of 7.69 ± 0.47 mM. Under the same conditions, whole sickle blood (n = 9) had normal [ATP] but significantly lower pHi (7.10 ± 0.03) and [Mg2+]free (0.32 ± 0.05 mM) than normal red cells, whereas [DPG] (10.8 ± 1.2 mM) was significantly higher. Because total magnesium was normal in sickle cells, the lower [Mg2+]free could be attributed to increased [DPG] and therefore greater magnesium binding capacity of sickle cells.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Magnesium is the second most abundant intracellular cation after potassium and is important in the regulation of more than 300 enzymes (1-3) and ion transport across cell membranes (4, 5). Some diseases, such as hypertension, pre-eclampsia, and sickle cell anemia exhibit pathologies linked to low magnesium levels (6-8). The genetic defect in sickle cell anemia results in the synthesis of an abnormal beta  hemoglobin (Hb) subunit, which polymerizes upon deoxygenation. This polymerization produces the characteristic sickle deformation in red blood cells and leads to microcirculatory occlusion and consequent tissue ischemia. Sickling depends strongly on the intracellular Hb concentration (9) and is enhanced by dehydration of erythrocytes, a process involving potassium and sodium transport across cell membranes, which is in turn thought to be regulated by cytosolic free magnesium, [Mg2+]free,1 via the KCl cotransporter (KCC1) (5, 10). Thus dehydration of sickle cells, and thereby the process of sickling, may be controlled by changes in the magnesium content (8, 11).

To assess its role in sickle cell anemia, an accurate and reproducible method was required for the measurement of [Mg2+]free. Although several methods have been developed to determine [Mg2+]free in red blood cells, such as null point titration with metallochromic dyes (12), magnesium-sensitive electrodes (13, 14), use of divalent cation ionophores (15), and 31P NMR spectroscopy (16, 17), the reported values vary 3-fold, from 0.2 to 0.6 mM (18-20). Of these methods, the one noninvasive technique that has been used extensively is that of 31P NMR spectroscopy (16-19, 21-25). However, there are a number of potential errors associated with using the observed NMR signal to determine [Mg2+]free, including uncertainty in the binding constant between ATP and magnesium (26), the effect of intracellular ionic content on this interaction (27), and the effect of metabolite-Hb interactions (23). Gupta and co-workers (2), the first to use this method, addressed the first two problems by determining an apparent MgATP binding constant, K(app)bMgATP, from the difference between the end points of the chemical shifts of the magnesium bound and unbound alpha  and beta  phosphorus nuclei of ATP, delta alpha beta -MgATP and delta alpha beta -ATP. This decreased the number of equilibria that had to be considered and overcame the need to rely on adjusted published values of K(app)b, which varied 100-fold (28). However, as with any simplification, problems are associated with this approach, which include the possible difference in ionic strength between solutions and in vivo conditions, the accuracy of the chemical shift end points required to determine K(app)b (29), and the assumption that delta alpha -ATP did not vary.

Because the chemical shifts of 31P NMR phosphorus peaks depend on many different factors (30), accurate analysis should take all factors into account, which has become possible with the increased capacity of computation. Previous analyses using phosphorus chemical shifts have been used to obtain either pH (24) or [Mg2+]free (16) in red blood cells. Only one approach used the 31P resonances of ATP to determine both pH and [Mg2+]free (31), but this averaged all ATP species with an apparent binding constant and made no allowance for the effect of Hb and K+ binding upon the observed chemical shift. It is possible that metabolite relaxation times become so long upon binding to Hb that such species do not contribute to the observed NMR peak, making them "NMR-invisible," and hence they could be omitted from analysis. Therefore, the effect of Hb on metabolite NMR "visibility" was investigated here. In addition, standard titration curves of ATP and DPG phosphorus chemical shifts were expressed in equations as functions of pH and [Mg2+]free. Adjusting these equations for Hb and K+ binding to ATP and DPG improved the method for measuring pH and [Mg2+]free in red blood cells. This newly developed NMR-based analysis allowed the simultaneous determination, for the first time, of the intracellular pH and [Mg2+]free in normal and sickle blood. Preliminary reports of this work have been published in abstract form (32, 33).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Preparation of Standard Solutions for Titration Curves-- Solutions were prepared as described previously (34) and contained 5 mM each K2ATP:2H2O, Na5DPG:3.5H2O (Sigma), and Pi (British Drug House, Poole), at 310.15 K and an ionic strength of 0.25. The pH of the solutions ranged from 5.75 to 8.50, and the total magnesium varied from 0 to 15.9 mM. Ionic strength was adjusted to 0.25 by adding KCl, and the pH was adjusted using 1 M KOH or HCl. In total, 130 samples were prepared, with 13 pH values, at 10 [Mg2+]free concentrations. Using the relevant equilibrium constants (Table I) for each particular ionic species, the amount of total MgCl2, [Mg]T, added to achieve a desired [Mg2+]free was calculated using the Equation 1,

                              
View this table:
[in this window]
[in a new window]
 
Table I
Acid dissociation constants (upper section) and equilibrium constants (lower section) at 37 °C, I = 0.25 and K+ = 0.2 used in Equation 2 to generate the required amounts of [Mg]T for the titration solutions


[Mg]<SUB>T</SUB> = [Mg<SUP>2+</SUP>]<SUB>free</SUB><FENCE>1+<LIM><OP>∑</OP></LIM><FENCE><FR><NU>[A]<SUB><UP>Ti</UP></SUB><UP> × K<SUB>bi</SUB></UP></NU><DE>f<UP>A<SUB>i</SUB></UP></DE></FR></FENCE></FENCE> (Eq. 1)
where f is a ratio of the ionized ligand, Az-, to the total ligand, AT.
fA<SUB><UP>i</UP></SUB>=<FENCE>A</FENCE><SUB><UP>Ti</UP></SUB>/<FENCE>A<SUP>2−</SUP></FENCE> (Eq. 2)
For the calibration solutions containing the three magnesium binding ligands, ATP, DPG, and Pi, the [Mg]T required for each solution was calculated from Equation 3.
<FENCE><UP>Mg</UP></FENCE><SUB><UP>T</UP></SUB>=<FENCE><UP>Mg</UP><SUP>2+</SUP></FENCE><SUB><UP>free</UP></SUB> (Eq. 3)

<FENCE>1+<FR><NU><FENCE><UP>P<SUB>i</SUB></UP></FENCE><SUB><UP>T</UP></SUB>×<UP>K</UP><SUP>b<UP> Mgp</UP><SUB><UP>i</UP></SUB></SUP></NU><DE>f<UP>P</UP><SUB><UP>i</UP></SUB></DE></FR>+<AR><R><C><FR><NU><FENCE><UP>ATP</UP></FENCE><SUB><UP>T</UP></SUB>×<FENCE>K<SUB>b<UP>MgATP</UP></SUB>+<FR><NU><FENCE><UP>H</UP><SUP>+</SUP></FENCE></NU><DE>K<SUB>a<UP>HATP</UP></SUB></DE></FR>−K<SUB>b<UP>HATP</UP></SUB></FENCE></NU><DE>f<UP>ATP</UP></DE></FR></C></R><R><C>+<FR><NU><FENCE><UP>DPG</UP></FENCE><SUB><UP>T</UP></SUB>×<FENCE><UP>K</UP><SUB>b<UP>MgDPG</UP></SUB>+<FR><NU><FENCE><UP>H</UP><SUP>+</SUP></FENCE></NU><DE>K<SUB>a<UP>HDPG</UP></SUB></DE></FR>−<UP>K</UP><SUB>b<UP>HDPG</UP></SUB></FENCE></NU><DE>f<UP>DPG</UP></DE></FR></C></R></AR></FENCE>

The solution of Equation 3 and the simultaneous equations involved in providing the correct ionic strength and pH (see Appendix I) were achieved using MathematicaTM (Wolfram Research, Champaign, IL). Using this method, MgCl2 was added to give solutions containing [Mg2+]free of 0, 0.05, 0.10, 0.25, 0.50, 0.75, 1.00, 1.25, 2.50, and 5.00 mM.

31P NMR Spectroscopic Analysis of Standard Solutions-- 31P NMR spectra of the solutions were acquired using a 9.4-tesla, Oxford Instruments wide bore superconducting magnet interfaced with a Varian Inova spectrometer operating at a phosphorus frequency of 161.9 MHz. A 10-mm probe was used, with the sample temperature set to 310.15 K. The homogeneity of the magnetic field was optimized by shimming on the 1H free induction decay to give 1H spectral line widths of 9 ± 2 Hz. For each sample, a 90o pulse (18.5 µs) was used with an interpulse delay of 15 s, a spectral width of 8 kHz, and no proton decoupling. The delay time was based on preliminary experiments in which T1 values were determined for sample solutions by running a preinstalled macro on the Varian spectrometer, using a standard inversion recovery method. Each spectrum consisted of 128 summed transients. Up to 256 transients were acquired for samples in which the beta -phosphorus of ATP was especially broad.

A capillary containing ~50 µl of 0.5 M phenylphosphonic acid was used as an external chemical shift reference, standardized relative to phosphocreatine at 0.00 ppm. Prior to Fourier transformation, the signal:noise ratio was increased by multiplying the 31P NMR free induction decays by an exponential function sufficient to generate a line broadening of 1 Hz, and the time domain signals were zero filled once. The NMR1 program (Tripos, St. Louis, MO) was used to fit peak areas, line widths, and chemical shifts of spectral resonances.

Theoretical Fitting of the Observed Chemical Shifts-- The chemical shifts for the 3-phosphorus of DPG and beta -phosphorus of ATP peaks were plotted against pH and [Mg2+]free, generating a three-dimensional surface. This was then fitted to an equation using the nonlinear fit algorithm in MathematicaTM with the main parameters being the chemical shifts of the H+, K+, and Mg2+ bound forms of beta -ATP and 3P-DPG, and the binding constants of each species to H+, K+, and Mg2+.

The equation used for fitting was based on the principle that the observed chemical shift (delta obs) could be described by combining the chemical shifts of all of the relevant forms of a substance present in the equilibrium and weighting their contribution to the observed chemical shift according to the ratio of their population to that of the total substance present (35).
&dgr;<SUB><UP>obs</UP></SUB>=<FR><NU><FENCE>X<SUB><UP>species 1</UP></SUB></FENCE></NU><DE><FENCE><UP>Total </UP> X</FENCE></DE></FR>×&dgr;<SUB><UP>species 1</UP></SUB>+<FR><NU><FENCE>X<SUB><UP>species 2</UP></SUB></FENCE></NU><DE><FENCE><UP>Total </UP>X</FENCE></DE></FR>×&dgr;<SUB><UP>species 2</UP></SUB>+… (Eq. 4)
Hence for ATP, assuming all ATP to consist of several species,
<FENCE><UP>ATP</UP></FENCE><SUB><UP>T</UP></SUB>=<FENCE><UP>ATP</UP><SUP>4−</SUP></FENCE>+<FENCE><UP>HATP</UP><SUP>3−</SUP></FENCE>+<FENCE><UP>H<SUB>2</SUB>ATP</UP><SUP>2−</SUP></FENCE>+<FENCE><UP>MgATP</UP><SUP>2−</SUP></FENCE> (Eq. 5)

+<FENCE><UP>MgHATP</UP><SUP>−</SUP></FENCE>+<FENCE><UP>KATP</UP><SUP>3−</SUP></FENCE>+<FENCE><UP>KHATP</UP><SUP>2−</SUP></FENCE>
the theoretical chemical shift can be described by Equation 6.
&dgr;<SUB>obs</SUB><FENCE><FR><NU><AR><R><C>[ATP<SUP>4−</SUP>] × &dgr;<SUB>ATP</SUB>+[HATP<SUP>3−</SUP>] × &dgr;<SUB>HATP</SUB>+[MgATP<SUP>2−</SUP>] × &dgr;<SUB>MgATP</SUB></C></R><R><C>+[MgHATP<SUP>−</SUP>] × &dgr;<SUB>MgHATP</SUB>+[KATP<SUP>3−</SUP>] × &dgr;<SUB>KATP</SUB></C></R><R><C>+[KATP<SUP>2−</SUP>] × &dgr;<SUB>KHATP</SUB>+[H<SUB>2</SUB>ATP<SUP>2−</SUP>] × &dgr;<SUB>H2ATP</SUB></C></R></AR></NU><DE>[ATP]<SUB>T</SUB></DE></FR></FENCE> (Eq. 6)
Using the equilibrium constants (assuming activity coefficients of unity), the concentrations of all forms can be expressed relative to the concentration of the completely ionized form (f values). Taking these and substituting in the above equation, the observed chemical shift is represented by Equation 7.
&dgr;<SUB><UP>obs</UP></SUB>=<FENCE><FR><NU><AR><R><C>&dgr;<SUB><UP>ATP</UP></SUB>+<FENCE><FR><NU>[<UP>H</UP><SUP>+</SUP>]</NU><DE>K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE>&dgr;<SUB><UP>HATP</UP></SUB>+(K<SUB>b<UP>MgATP</UP></SUB>×[<UP>Mg</UP><SUP>2+</SUP>])&dgr;<SUB><UP>MgATP</UP></SUB>+</C></R><R><C><FENCE><FR><NU>K<SUB>b<UP>MgHATP</UP></SUB>×[<UP>Mg</UP><SUP>2+</SUP>][<UP>H</UP><SUP>+</SUP>]</NU><DE>K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE>&dgr;<SUB><UP>MgHATP</UP></SUB>+(K<SUB>b<UP>KATP</UP></SUB>×[<UP>K</UP><SUP>+</SUP>])&dgr;<SUB><UP>KATP</UP></SUB>+</C></R><R><C><FENCE><FR><NU>K<SUB>b<UP>KHATP</UP></SUB>×[<UP>K</UP><SUP>+</SUP>][<UP>H</UP><SUP>+</SUP>]</NU><DE>K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE>&dgr;<SUB><UP>KHATP</UP></SUB>+<FENCE><FR><NU>[<UP>H</UP><SUP>+</SUP>]<SUP>2</SUP></NU><DE>K<SUB>a<UP>HATP</UP></SUB>×K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE>&dgr;<SUB><UP>H<SUB>2</SUB>ATP</UP></SUB></C></R></AR></NU><DE><AR><R><C>1+<FENCE><FR><NU>[<UP>H</UP><SUP>+</SUP>]</NU><DE>K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE>+(K<SUB>b<UP>MgATP</UP></SUB>×[<UP>Mg</UP><SUP>2+</SUP>])+<FENCE><FR><NU>K<SUB>b<UP>MgHATP</UP></SUB>×[<UP>Mg</UP><SUP>2+</SUP>][<UP>H</UP><SUP>+</SUP>]</NU><DE><UP>K</UP><SUB><UP>aATP</UP></SUB></DE></FR></FENCE></C></R><R><C>+(K<SUB>b<UP>KATP</UP></SUB>×[<UP>K</UP><SUP>+</SUP>])+<FENCE><FR><NU>K<SUB>b<UP>KHATP</UP></SUB>×[<UP>K</UP><SUP>+</SUP>][<UP>H</UP><SUP>+</SUP>]</NU><DE>K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE></C></R><R><C>+<FENCE><FR><NU>[<UP>H</UP><SUP>+</SUP>]<SUP>2</SUP></NU><DE>K<SUB>a<UP>HATP</UP></SUB>×K<SUB>a<UP>ATP</UP></SUB></DE></FR></FENCE></C></R></AR></DE></FR></FENCE> (Eq. 7)

Similarly for DPG, the following equation describing the observed chemical shift for DPG was formulated, assuming the forms present were DPG5-, HDPG4-, H2DPG3-, MgDPG3-, MgHDPG2-, KDPG4-, and KHDPG3-.
&dgr;<SUB>obs</SUB>=<FENCE><FR><NU><AR><R><C>&dgr;<SUB>DPG</SUB>+<FENCE><FR><NU>[H<SUP>+</SUP>]</NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE>&dgr;<SUB>HDPG</SUB>+(K<SUB>bMgDPG</SUB> × [Mg<SUP>2+</SUP>])&dgr;<SUB>MgDPG</SUB>+<FENCE><FR><NU>K<SUB>bMgHDPG</SUB> × [Mg<SUP>2+</SUP>][H<SUP>2+</SUP>]</NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE>&dgr;<SUB>MgHDPG</SUB></C></R><R><C>+(K<SUB>bKDPG</SUB> × [K+])&dgr;<SUB>KDPG</SUB>+<FENCE><FR><NU>K<SUB>bKHDPG</SUB> × [K<SUP>+</SUP>][H<SUP>+</SUP></NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE>&dgr;<SUB>KHDPG</SUB>+<FENCE><FR><NU>[H<SUP>+</SUP>]<SUP>2</SUP></NU><DE>K<SUB>aHDPG</SUB> × K<SUB>aDPG</SUB></DE></FR></FENCE>&dgr;<SUB>H2DPG</SUB></C></R></AR></NU><DE><AR><R><C>1+<FENCE><FR><NU>[H<SUP>+</SUP>]</NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE>+(K<SUB>bMgDPG</SUB> × [Mg<SUP>2+</SUP>])+<FENCE><FR><NU>K<SUB>bMgHDPG</SUB> × [Mg<SUP>2+</SUP>][H<SUP>+</SUP>]</NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE></C></R><R><C>+(K<SUB>bKDPG</SUB> × [K<SUP>+</SUP>])+<FENCE><FR><NU>K<SUB>bKHDPG</SUB> × [K<SUP>+</SUP>][H<SUP>+</SUP>]</NU><DE>K<SUB>aDPG</SUB></DE></FR></FENCE>+<FENCE><FR><NU>[H<SUP>+</SUP>]<SUP>2</SUP></NU><DE>K<SUB>aHDPG</SUB> × K<SUB>aDPG</SUB></DE></FR></FENCE></C></R></AR></DE></FR></FENCE> (Eq. 8)

The substitution of [H+] to 10-pH was used to make the equations more convenient. "Goodness" of fit may be determined by chi 2, where
&khgr;<SUP>2</SUP>=<AR><R><C><LIM><OP>∑</OP></LIM></C></R><R><C>i</C></R></AR>‖F<SUB>i</SUB>−f<SUB>i</SUB>‖<SUP>2</SUP> (Eq. 9)
with Fi the value of the ith data point, and fi is the value obtained from the fit.

Model of the Red Blood Cell-- The chemical shifts of the intermediate species were calculated from the above fitting equations and were used in new multiple equilibria equations, which included the binding of Hb to ATP4-, MgATP2-, and DPG5-. To achieve this, it was assumed that the chemical shifts of each species were not affected by binding to Hb (2, 14). Binding constants for Hb were taken from Berger et al. (36), where KbHbATP is 360 M-1, KbHbMgATP is 39 M-1, and KbHbDPG is 250 M-1.

Therefore,
(Eq. 10)

(Eq. 11)
The above equations are simplified from the MathematicaTM program presented in Appendix II.

After determination of chemical shifts of the beta -phosphate peak of ATP (delta beta ) and the phosphate on the 3 carbon of DPG (delta 3P) from acquired spectra of red blood cells, these equations were solved simultaneously to calculate pH and [Mg2+]free in red blood cells using the Solve algorithm in Mathematica (Appendix II). A requirement of this method is that the total amounts of ATP, DPG, Hb, and K+ must be entered in the algorithm before a solution can be found. ATP and DPG concentrations were assayed as described below, and Hb and K+ concentrations (mmol/liter cell water) were assumed to be 7 mM (2, 37) and 160 mM (38), respectively. Erythrocyte total magnesium was calculated by summing the concentrations of all magnesium-containing species, determined from the solution of this algorithm, for comparison with the total magnesium determined using a standard colorimetric assay (see later).

Preparation of Whole Human Blood Samples-- This study was approved by the Ethics Committee, Medical School, University of Birmingham. Blood from volunteers (8-10 ml) or from consenting homozygous sickle cell disease (HbSS) patients (5 ml) was collected by venipuncture into lithium-heparinized syringes. To simulate in vivo fully oxygenated blood, whole blood samples were prepared for analysis by equilibration with a mixture of O2 and CO2 (95%:5%), adjusted to give a final PCO2 of 40 mmHg and PO2 between 200 and 400 mmHg, determined using a blood gas analyzer (Radiometer ABL 330). The PO2, PCO2, and pHex were measured before and after NMR analysis, at which time the PO2 remained > 150 mm Hg, to ensure complete oxygenation at all times during analysis. To minimize cell degradation, time from phlebotomy to analysis was kept to a minimum (1-3 h), during which blood samples were stored on ice.

Separation of Sickle Cells by Density-- Sickle cells are heterogeneous with respect to total magnesium, DPG content, and pH (39, 40), which vary with cell density as the cell sickles, therefore we separated sickle cells into three fractions using a discontinuous arabinogalactose density gradient before analysis, thereby allowing comparison with unfractionated whole sickle blood. Cells were fractionated on discontinuous density gradients of Stractan II (arabinogalactan) as described previously (41) with minor modifications (42).2 All separations were performed at 4 °C in a cold room to maintain ATP concentrations. Briefly, two iso-osmotic Stractan density layers, 1.090 and 1.099 g/ml, were used with a cushion of 1.196 g/ml. Blood (20 ml) was collected from six consenting HbSS patients, unmatched for blood antigen type (one with blood group A, one with blood group O, and four with blood group B). Following centrifugation at 3,000 × g for 10 min, plasma was removed and stored on ice, and the buffy coat was carefully removed and discarded. Each of the six packed blood cell samples was washed twice with ice-cold buffer containing 5 mM KCl, 145 mM NaCl, 0.05 mM EGTA, 0.2 mM MgCl2, 10 mM Na-HEPES, pH 7.4. For each experiment, cells from two patients were pooled to give a total of 8-10 ml of packed cells, which were layered on the Stractan gradient. After ultracentrifugation, three lay-ers were harvested, light (d < 1.090 g/ml), medium (1.090 g/ml < d < 1.099 g/ml), and dense (d > 1.099 g/ml), with the dense layer containing most of the irreversibly sickled cells. The density-fractionated red cells were washed three times at 4 °C, using the above buffer, before being resuspended in pooled, heparinized plasma from the same two patients, to give final hematocrits of 35-50%. Normal ATP concentrations (see later) and microscopic observation at high magnification showed that no agglutination occurred in the pooled, unmatched blood samples, possibly because of the high heparin concentrations (43). The "whole blood" samples were prepared for NMR analyses as described above. The time taken from phlebotomy to NMR analyses was 5-7 h.

31P NMR Spectroscopy of Human Red Blood Cells-- 31P NMR spectra of the cells were acquired using the magnet and spectrometer described above. The fully oxygenated whole blood (~ 4.5 ml), prepared as above, was sealed in a 10-mm NMR sample tube together with an external reference capillary containing 50 µl of 0.3 M phenylphosphonic acid and brought to 37 °C before 31P NMR spectroscopic analysis in a 10-mm probe. The probe temperature was set to 310.15, the samples were not spun, and no proton decoupling was used. The homogeneity of the magnetic field was optimized by shimming on the 1H free induction decay to a line width of 30 ± 2 Hz (normal cells) or 23 ± 2 Hz (sickle cells). A 45° pulse was used with an interpulse delay of 0.52 s to give peaks of a high signal:noise ratio (25). The spectral width was 8 kHz, with an acquisition time of 0.272 s (4,500 data points), and 2048 transients were summed. The samples were at 37 °C for a maximum of 38 min. Prior to Fourier transformation, the signal:noise ratio was increased by multiplying the 31P NMR free induction decays by an exponential function sufficient to generate a line broadening of 7 Hz, and the time domain signals were zero filled once, giving a digital resolution of 1.1 Hz/point. The NMR1 program was used to fit peak areas, line widths, and chemical shifts of spectral resonances.

Chemical Assays-- Immediately after the NMR measurement, the blood was poured from the NMR tube and samples taken for light microscopy to count the number of sickled cells, and for determination of hematocrit and ATP and DPG concentrations using diagnostic kits (Sigma). Total magnesium concentrations in plasma and trichloroacetic acid extracts of whole blood were determined in duplicate using diagnostic kits (Sigma). The total erythrocyte magnesium concentrations were then calculated by subtracting the plasma total magnesium from the whole blood measurement. Concentrations are presented per liter of cell water, assuming a 95% packing efficiency and 70% cellular water content for normal cells, 66% for whole sickle blood, and 65 and 62% for medium and dense sickle cells, respectively (37). The hematocrits were determined after centrifugation at 13,000 × g for 10 min in a microhematocrit centrifuge using a Hawksley microhematocrit reader, with all measurements made in triplicate.

Effect of Hb on ATP and DPG NMR Visibility-- To alleviate concerns that metabolites bound to Hb would be NMR-invisible, solutions were prepared containing 2 mM K2ATP:2H2O, 7 mM Na5DPG:3.5H2O (Sigma), 190 mM KCl, 3 mM MgCl2:6H2O with and without 6 mM human Hb (Sigma), and the pH was adjusted to 7.2 at 37 °C using 1 M KOH or HCl. 31P NMR spectra of the solutions were acquired as described above. Immediately after the NMR measurement, ATP and DPG concentrations were determined as described above.

Statistics-- Data are presented as means ± S.D. Significance was tested using analysis of variance, with repeated measures where appropriate, with p < 0.05 considered significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Typical 31P NMR spectra of the titration solutions acquired between a pH 6 of 8 and [Mg2+]free between 0 and 5 mM are shown in Fig. 1. The ATP, DPG, and Pi peaks increased in chemical shift as pH increased, reflecting a decrease in electronic shielding upon proton association. The maximal chemical shift changes are given in Table II. Increasing [Mg2+]free altered the delta  of all ATP peaks (beta  (3.26 ppm) and gamma  (3.72 ppm) more than alpha  (0.46 ppm)) but led to only slight changes in those of Pi (0.03 ppm) and 3P- and 2P-DPG (0.34 and 0.76 ppm, respectively). The chemical shifts of the 2P-DPG and Pi peaks were more sensitive to changes in pH than to changes in magnesium (3.15 and 2.35 ppm, respectively), whereas those of the beta - and gamma -phosphate peaks of ATP were equally sensitive to both pH and [Mg2+]free. At the physiological pH of 7.2 and [Mg2+]free of 0.3 mM, the beta -ATP triplet could not be fully resolved because of line broadening caused by chemical exchange, but the peak could still be used for chemical shift determination. The Pi peak overlapped with the 2P-DPG doublet, thus neither could be used for pH or [Mg2+]free determination in red blood cells. Instead, it was necessary to use the 3P-DPG peak.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 1.   Spectra of the standard solutions over the pH range 5.75-8.5 and [Mg2+]free concentrations 0-5 mM. A spectrum typically expected for blood at physiological conditions of a pH of 7.2 and [Mg2+]free 0.3 mM is central.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Maximum chemical shift changes of all phosphate groups at different pH and/or [Mg2+]free

Three-dimensional Curves from the Chemical Shifts of beta -Phosphate of ATP and 3-Phosphate of DPG-- Using the observed beta -ATP peak chemical shifts (delta beta ), a three-dimensional surface curve was generated as a plot of pH and [Mg2+]free with the section relevant to physiological conditions expanded (Fig. 2a). Equation 7 was fitted to these data and plotted in Fig. 2b. Using the observed 3P-DPG peak chemical shifts (delta 3P), a three-dimensional surface curve was generated as a plot of pH and [Mg2+]free (Fig. 3a). Equation 8 was fitted to these data and plotted in Fig. 3b. The final values of the fitting parameters of chemical shifts and explicit equilibrium constants are given in Table III.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Plot of the observed chemical shift (a) and the curve produced by the fitting equation (b) of the chemical shift of beta -ATP against pH and [Mg2+]free, expanded to show the physiological region.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   Plot of the observed chemical shift (a) and the curve produced by the fitting equation (b) of the chemical shift of 3P-DPG against pH and [Mg2+]free.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Parameters used to produce the best fit of the theoretical chemical shift to that of the observed, including interactions with potassium
Equilibrium constants are explicit binding constants at 37 °C and I = 0.25. Chemical shifts are presented as ppm relative to phosphocreatine at 0 ppm. Errors are presented as standard errors.

Effect of Hb on ATP and DPG NMR Visibility-- The line widths of DPG and ATP peaks each increased by 60% on addition of Hb (alpha -LW from 28 to 45 Hz, and beta -LW from 50 to 80 Hz). Despite this, when the normalized peak integral was divided by the assayed total metabolite concentration, the values changed by less than 3% on addition of Hb. This indicated that ATP and DPG NMR visibility was not significantly impaired by binding to Hb, in that the Hb-bound component of the observed chemical shift was not so broad as to be lost in the noise of the spectrum.

Fig. 4 shows a typical 31P NMR spectrum of normal red blood cells. The DPG peaks were relatively sharp (LW congruent  20 Hz), whereas the line width of the beta  phosphate of the ATP peak was significantly greater than the line widths of the other ATP peaks (beta -LW congruent  65 Hz, alpha -LW congruent  35 Hz). Using the 3P-DPG and beta -ATP phosphate peak chemical shifts, the intracellular pH and [Mg2+]free were determined simultaneously using the values of ATP and DPG determined by enzymatic analysis.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   A typical 31P NMR spectrum of normal red blood cells.

Analysis of Normal and Sickle Red Blood Cells-- Fractionation of the 8-10 ml of packed sickle cells gave fraction volumes in the approximate ratio 3:5:2 for light:medium:dense fractions. When resuspended in their plasma, the hematocrits were in the range of 35-50%. Morphological microscopic examination, as estimated by criteria described previously (42), revealed that the dense fraction contained between 50 and 70% irreversibly sickled cells, the medium contained ~5%, and the light had fewer than 1%.

The determined levels of DPG, ATP, pHi, [Mg2+]free, and MgT, both predicted using the model and assayed, are presented in Table IV for normal and sickle whole blood and for each of the separated sickle cell fractions, light, medium, and dense. DPG was elevated significantly in all three sickle cell fractions, by a maximum of 2.4 mM in the medium density fraction, compared with normal blood cell DPG of 7.7 mM. However, the DPG concentration of the dense cells was significantly lower than that of the other sickle cells, but not as low as the normal cells. ATP was normal in all of the sickle cell samples. The PCO2 of whole blood and cell fractions was set to be the same for all the analyses, which gave normal blood a measured pHex of 7.39 ± 0.03. However, at a PCO2 of 40 mm Hg, the pHex of whole sickle blood was 0.07 pH unit more acidic than normal blood. After fractionation, the pHex of sickle cells was 0.23 pH unit more acidic than whole control blood. The PO2 never dropped below 150 mm Hg and usually was around 300 mm Hg. In parallel with their more acidic pHex, the pHi of all sickle cell samples was 0.10-0.13 pH unit more acidic than normal cells. [Mg2+]free was decreased significantly by ~0.09 mM in the medium and the dense cells, and in the whole sickle blood compared with normal cells. There was no change in MgT, either predicted from the model or measured by assay.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
ATP, DPG, pCO2, pHex, pHi, [Mg2+]free, and total Mg concentrations (µmol/ml intracellular water) in normal and sickle red blood cells
Data are presented as means ± S.D.

Thus, using this new method, which considered all significant interactions between metabolites, H+, K+, Mg2+, and Hb, oxygenated sickle blood had normal ATP concentrations and significantly lower pHex, pHi, and [Mg2+]free than normal cells, both in the dense fractions after separation and as unfractionated whole blood.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Less than 0.5% of body magnesium resides in blood plasma, and yet plasma total magnesium is commonly used as a marker of body magnesium status because of the absence of an easy reproducible method for measuring [Mg2+]free. Because intracellular [Mg2+]free is important in regulating biochemical reactions, it may serve as a better marker of status, and, of all tissues, red blood cells are the most readily available for study in humans. The best method by which to measure [Mg2+]free is frequently discussed, but the effect of pH on [Mg2+]free measurements is often not taken fully into account (27). Consequently, we have developed a method to quantify both [Mg2+]free and pH in red blood cells under a wide range of conditions.

Observed Chemical Shift versus pH and [Mg2+]free-- From the plot of the chemical shift of 3P-DPG, it can be seen that delta 3P did not significantly change with [Mg2+]free, other than at high pH (>7.8) and very low [Mg2+]free (<0.1 mM). This suggested that delta 3P could be used as a good indicator of physiological pH. The chemical shift of the beta  phosphate of ATP changed significantly with both pH and [Mg2+]free in the physiological region to allow an accurate determination of pH and [Mg2+]free from the observed chemical shifts. A change in chemical shift of ~0.05 ppm corresponded to a 0.015 mM change in [Mg2+]free at constant pH.

The equations relating the observed chemical shift of 3P-DPG and beta -ATP and to pH and Mg2+ accurately fitted both experimental curves using the theoretical equations (Equations 7 and 8). These equations were solved simultaneously to determine both intracellular pH and [Mg2+]free in normal and sickle red blood cells (Table IV).

31P NMR studies (44) on the effects of Mg2+ on ATP have shown that Mg2+ induces the greatest chemical shift on the beta -phosphorus and the least on the alpha -phosphorus resonance of ATP. This has been interpreted as indicating that Mg2+ binds mainly to the beta - and gamma -phosphate groups (45, 46), possibly via a cyclic six-membered transition state that is energetically favored (Fig. 5) and has little interaction with the alpha  residue. Thus, previous studies have used the changing difference of the chemical shift of the beta  from the alpha  resonance of ATP, delta alpha beta , to determine intracellular [Mg2+]free in many tissue types (16, 47, 48) and thereby use the alpha -ATP peak as an internal chemical shift standard. However, it was seen (Fig. 1) that the alpha -phosphate chemical shift was not only variable over the ranges of pH and magnesium studied, but also alpha -phosphorus and beta -phosphorus changed as pH and magnesium were varied. Therefore, in this study, all chemical shifts were measured relative to an external capillary standard.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 5.   Possible structure of MgATP2-, with Mg2+ bound in an energetically favored six-member cyclic transition state.

Use of Explicit Equilibrium Constants-- One important new aspect of this study was the use of explicit equilibrium constants as opposed to apparent constants, which allows the ready adaptation of the technique to a much wider range of conditions, either in red blood cells or other tissues. However, it also necessitates that a greater number of constants be accurate. This necessity was overcome in the original method of Gupta et al. (16) by measuring an apparent dissociation constant for MgATP, K(app)dMgATP, under in vitro conditions thought appropriate to the in vivo situation. However, this had three major problems. First, the two conditions would not have the same ionic strength, despite possessing same concentration of K+. This is because of the presence of other charged species, such as DPG, in the in vivo environment, and therefore the measured K(app)dMgATP would also differ between in vitro and in vivo conditions. For example, the ionic strengths would have changed from 0.16 to 0.19 M as ATP and magnesium concentrations were varied in the in vitro solutions. The addition of 7 mM DPG would have increased the ionic strength to 0.24 M in vivo. Assuming that K(app)dMgATP was measured at 0.17 M ionic strength to be 38 mM, it would correspond to ~60 mM at this in vivo ionic strength (adjusted using standard thermodynamic equations (3)). Because the calculated [Mg2+]free is directly proportional to K(app)dMgATP this would have the effect of also increasing [Mg2+]free by a factor of 1.5. Second, an accurate assessment of K(app)dMgATP from 31P NMR requires an accurate knowledge of the chemical shift end points delta ATP and delta MgATP. Although delta ATP may be relatively straightforward to determine, delta MgATP is more difficult because of the presence of the Mg2ATP species, which would affect the overall observed chemical shift (29). Third, rather than absolute chemical shifts, the difference between delta alpha -ATP and delta beta -ATP was used to determine K(app)dMgATP, assuming that neither was particularly affected by pH near neutrality. However, this is not the case at extreme magnesium levels where binding constants are determined.

One further limitation of this approach, although it might, in theory, alleviate the need to know the exact effect that intracellular ionic content would have on binding interactions, is that it places restrictions on how readily the method can be applied under a range of conditions. For each new intracellular condition, including a pH change, a new apparent binding constant would have to be determined experimentally.

Effect of K+-- Different physiological conditions may have different potassium concentrations. Changing [K+] exerts not only an effect on KbMgATP, because of changing the ionic strength, but also an effect on the observed chemical shift by changing the amount of potassium-bound species (27). By assuming KX and KHX species existed for both DPG and ATP, a significant improvement in the mathematical fit of the observed data occurred, with chi 2 decreasing by 50 and 90% for DPG and ATP curves, respectively (data not shown). As a verification of this model, the new value for the explicit MgATP2- binding constant of 7.50 × 104 M-1 was in excellent agreement to that calculated by Mulquiney and Kuchel (37), which approximated to 8.0 × 104 M-1 when adjusted for pH and ionic strength.

Effect of Hb on Metabolite NMR Visibility-- If the metabolite relaxation times were sufficiently long when bound to Hb, the Hb-bound component of the overall observed chemical shift would be broad enough to be lost in spectral noise. Thus, Hb-bound metabolites would be NMR-invisible and could be omitted from the analysis. However, we found no loss in metabolite visibility on binding to Hb, so the effect of oxygenated Hb binding must be included in the analysis of [Mg2+]free. Furthermore, when the concentration of ATP in red blood cells was estimated from the relative peak integrals of ATP and DPG in the observed spectra using the assayed concentration of DPG, there was less than a 10% variation between this value and that of the spectrophotometrically measured ATP concentration. This confirms the finding that DPG and ATP remain NMR-visible when bound to Hb.

Effect of Hemoglobin Binding on [Mg2+]free Analysis-- In the original 31P NMR method, the effect that metabolite-Hb interactions had on the equilibria was considered (16). However, by 1983 (48), this complexity in the method was lost, perhaps because, according to their equilibrium constants, Hb bound MgATP and ATP equally strongly, which would allow the Hb effect to be ignored (23). Also, this added complexity, combined with the lack of computational power at the time, perhaps made solving the necessary multiple equilibria too difficult to be achieved routinely. A disregard of the effect of Hb has existed ever since, until 1997 when the effect of metabolite-Hb interactions was reevaluated (23).

The standard titration solutions did not include Hb because the extent of DPG and ATP binding to Hb was uncertain, and its effect would complicate the analysis of the important interactions among H+, Mg2+, K+, ATP4-, and DPG5-. However, after the observed experimental chemical shifts were modeled by equations describing the effect of all intermediates as functions of H+ and Mg2+, these equations were altered to allow for Hb binding (Equations 10 and 11). Although each equilibrium is independent of every other, and therefore the addition of Hb cannot, per se, alter the magnesium binding ATP equilibrium, the observed chemical shift is not independent because it intrinsically reflects a weighted average of all species present. Therefore the effect of Hb binding on the observed chemical shifts of both DPG and ATP must be taken into account. This can be achieved, to a first approximation, by assuming that chemical shifts did not change when metabolite species bound to Hb. This is true within a 5% error in oxygenated erythrocytes (2, 23). Simultaneous equations were then formulated which included the effect that Hb binding had on the equilibria for ATP and DPG and hence on the overall observed chemical shifts (Equations 10 and 11 and Appendix II). These equations also required the binding constants for Hb binding to DPG, ATP, and MgATP. There are two generally accepted sets of constants (2), which largely agree except on the value of MgATP binding to Hb. This affected the positions of the equilibria to a different extent as illustrated in Fig. 6, a and b) for the analysis of pH and [Mg2+]free with a total ATP of 2 mM, a total DPG of 5 mM, and a total Hb of 7 mM.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of allowing Hb binding to ATP, MgATP, and DPG on the theoretical chemical shift beta -ATP (a) and 3P-DPG (b), with no Hb (line), with 2 mM ATP, 5 mM DPG, and 7 mM Hb and using equilibrium constants from either Gupta et al. (2) (longer dashes) or Berger et al. (36) (shorter dashes).

This difference led to discrepancies in the calculated values of pHi and [Mg2+]free. For comparison, for normal blood, pH, and [Mg2+]free were determined to be 7.23 ± 0.01 and 0.41 ± 0.04 mM, respectively, using Berger's constants (36), but 7.25 ± 0.01 and 0.21 ± 0.03 mM using those of Gupta et al. (2). The analysis presented under "Results" used Berger's constants because errors may be associated with the methodology (23) used by Gupta (16).

Effect of K+ and Hb-- For a complete description of the erythrocyte, the effects of both K+ and Hb should be taken into account. However, once K+ is specified in the magnesium-ATP equilibrium, it also needs to be specified in the ATP-Hb equilibrium. Both Berger (36) and Gupta (2) measured apparent Hb binding constants using a physiological [K+], and therefore there are no data available on binding between KATP/KHATP and Hb. However, if realistic binding constants were estimated such that the overall binding of "ATP" (ATPfree, HATP, KATP, KHATP) to Hb remained equal to that measured by Berger, a realistic possible adjustment to the theoretical equations can be made. Including all effects of both K+ and Hb, this provided a complete model of erythrocyte conditions and led to an estimation of pH and [Mg2+]free in normal red blood cells of 7.20 and 0.41 mM, respectively (Table IV). Although this model included estimated values for some binding constants, it can be partly verified by summing all MgX species to find the model prediction for erythrocyte total magnesium. This was calculated to be 3.1 mM, which is ~90% of that found experimentally. However, the model does not include the low affinity binding of Mg2+ to Hb, which, it has been suggested, can account for the remaining 10% (49). Because Mg2+ does not compete with ATP and DPG in binding Hb, this factor did not significantly change the analysis for [Mg2+]free.

Comparisons with Previous Methods-- In the most common analysis of NMR spectra to yield [Mg2+]free (16, 48, 50), delta ATP and delta MgATP end points and an apparent dissociation constant are determined from in vitro solutions. It is then assumed that pHi is 7.2.


<FENCE><UP>Mg</UP><SUP>2+</SUP></FENCE><SUB><UP>free</UP></SUB>=K<SUB>(<UP>app</UP>) d<UP> MgATP</UP></SUB>×<FENCE>&dgr;<SUB><UP>ATP</UP></SUB>−&dgr;<SUB><UP>obs</UP></SUB></FENCE>/<FENCE>&dgr;<SUB><UP>obs</UP></SUB>−&dgr;<SUB><UP>MgATP</UP></SUB></FENCE> (Eq. 12)
Following this procedure, using end points determined here and assuming K(app)dMgATP = 38 µM (51), [Mg2+]free was calculated to be 0.24 ± 0.02 and 0.16 ± 0.02 mM for normal and sickle cells, respectively, significantly different from the values of 0.41 ± 0.03 and 0.32 ± 0.05 mM found in this work (Table V). Also, a comparison was made with values calculated using the original technique (16), where pHi is, again, assumed to be 7.2, but Hb interactions are included. This also leads to significantly different values.

                              
View this table:
[in this window]
[in a new window]
 
Table V
Analysis of spectral data from human red blood cells with comparisons with other methods used

Use of Explicit Constants for the Generation of in Vitro Solutions-- Solutions are often required in experimental practice to mimic the conditions found in vivo. These frequently require an accurate [Mg2+]free in ATP-containing solutions, but all too often this is calculated using equilibrium constants that are inappropriate for the conditions used. This is partly because of constants being quoted as apparent ones, thus making it difficult to adjust them over a range of conditions. However, in this work, explicit constants have been determined which readily allow the generation of a specific [Mg2+]free in an ATP-containing solution over any range of pH, potassium, ATP, DPG, Hb, temperature, and ionic strength. Furthermore, this technique can be used in other cell types if a replacement peak chemical shift is used instead of DPG, ideally Pi.

Normal versus Sickle Red Blood Cells-- We went on to compare normal red cells with those from sickle patients. We found that well oxygenated sickle cells had significantly lower [Mg2+]free and pHi than normal red cells but unchanged [ATP]. Our results agree well with the seminal study by Ortiz and co-workers (40), conducted using the null point (A23187) method. Thus, values for [DPG], [Mg2+]free, and MgT in normal red cells were very similar in the two studies. In both studies, oxygenated sickle cells had high [DPG], low [Mg2+]free, and unchanged MgT. A reduction in [Mg2+]free in sickle cells, compared with normal cells, could result from an increased buffering capacity for magnesium because of high [DPG], concomitant with unchanged [ATP]. We also found similar results in our oxygenated dense (density > 1.099 g/ml) sickle cell fraction. By contrast, in their dense fraction (density > 1.118 g/ml), Ortiz et al. (40) reported an increased [Mg2+]free and decreased MgT. This elevation in [Mg2+]free was markedly exacerbated on deoxygenation, reversing the usual inward magnesium concentration gradient and providing a mechanism for the magnesium depletion that they observed in this fraction. The difference in oxygenated dense cells between the two studies could be attributed to the difference in the densities chosen for cell fractionation and/or a difference in magnesium buffering. Although the blood samples were gassed with 95% O2 to produce a PO2 >150 mm Hg, it is possible that the dense sickle cells were not fully oxygenated, causing sickle Hb (Hb S) to polymerize (52). To our knowledge, there are no constants available for binding of metabolites to Hb polymer, but polymerization would alter [Mg2+]free estimated using our method and may explain the low [Mg2+]free in the dense cell fraction.

We found that the pHi of whole sickle blood was 0.10 pH unit more acidic than that of normal red cells, with a pHi of 7.10, in agreement with previous NMR studies of buffer-washed red cells (24). However, at the same PCO2, sickle blood pHex was also significantly more acidic, by 0.07 pH unit, than normal.

Low [Mg2+]free and low pH will both activate KCC1 (53), which may partially explain the high activity of this transporter in sickle cells. Cell shrinkage, perhaps via overactivity of KCC1, remains the principal hazard in irreversible sickling. For a patient with sickle cell anemia in a steady state, the percentage of red blood cells that are irreversibly sickled is about 15%. With a hematocrit of 20%, this corresponds to 3% of total blood volume. Therefore, although it is important to fractionate cells and analyze the dense cell fraction to understand the mechanisms underlying cell sickling, it is clinically important to analyze whole sickle blood, using considerably smaller volumes, to assess the in vivo state of the majority of red blood cells in an effort to prevent sickling.

In summary, we have modeled the observed chemical shift of beta -ATP and 3P-DPG over a wide range of pH and [Mg2+]free using appropriate theoretical equations. These equations included contributions to the overall chemical shift from all possible intermediates present in solution and represented the multiple equilibria formed by the interactions among H+, Mg2+, K+, ATP4-, and DPG5-. An adjustment for Hb binding was made to the equations to allow a new, more complete, determination of intracellular pH and [Mg2+]free using 31P NMR spectroscopic analysis of red blood cells. Thus, pHi and [Mg2+]free were determined in whole, oxygenated normal and sickle blood, with pHex, [Mg]T, ATP, and DPG concentrations. The pHi, pHex, and [Mg2+]free were significantly lower in sickle cells, whereas [DPG] was significantly higher, with no changes in [ATP].

    ACKNOWLEDGEMENTS

We thank Nurse Sue Stevens for kind assistance with the blood samples, Asif Khan for help with the preparation of the Stractan gradients, and Drs. V. L. Lew and J. F. Gibson for invaluable advice.

    FOOTNOTES

* This work was supported in part by the British Heart Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at www.jbc.org) contains Appendices I and II.

Dagger Recipient of a Ph.D. studentship from the Biotechnology and Biological Sciences Research Council.

§ Supported by the Australian National Health and Medical Research Council.

** To whom correspondence should be addressed. Tel.: 44-1865-275-255; Fax: 44-1865-275-259; E-mail: Kieran.Clarke@bioch.ox.ac.uk.

Published, JBC Papers in Press, September 23, 2002, DOI 10.1074/jbc.M207551200

2 V. L. Lew, personal communication.

    ABBREVIATIONS

The abbreviations used are: [Mg2+]free, concentration of unbound magnesium; beta -ATP, phosphate group at the beta  position of ATP; DPG, 2,3-diphosphoglycerate; delta alpha beta -MgATP and delta alpha beta -ATP, chemical shift difference between alpha - and beta -phosphorous nuclei of ATP when bound to magnesium and unbound, respectively; delta obs, observed chemical shift; K(app)bMgATP , apparent MgATP binding constant; K(app)dMgATP, apparent dissociation constant for MgATP; LW, half-peak line width; MgT, total concentration of magnesium; 2P- and 3P-DPG, phosphate group on the second and third carbon atom of DPG, respectively.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Gerber, G., Preissler, H., Heinrich, R., and Rapport, S. M. (1974) Eur. J. Biochem. 45, 39-52[Medline] [Order article via Infotrieve]
2. Gupta, R. K., Benovic, J. L., and Rose, Z. B. (1978) J. Biol. Chem. 253, 6165-6171[Free Full Text]
3. Lawson, J. W. R., and Veech, R. L. (1979) J. Biol. Chem. 254, 6528-6537[Abstract/Free Full Text]
4. Stephenson, E. W., and Podolsky, R. J. (1977) J. Gen. Physiol. 69, 1-16[Abstract/Free Full Text]
5. Flatman, P. W. (1988) J. Physiol. (Lond.) 397, 471-487[Abstract/Free Full Text]
6. Resnick, L. M., Gupta, R. K., Gruenspan, H., Alderman, M. H., and Laragh, J. H. (1990) Am. J. Hypertens. 3, 373-379[Medline] [Order article via Infotrieve]
7. Duley, L. (2002) Lancet 359, 1877-1890[CrossRef][Medline] [Order article via Infotrieve]
8. De Franceschi, L., Bachir, D., Galacteros, F., Tchernia, G., Cynober, T., Alper, S., Platt, O., Beuzard, Y., and Brugnara, C. (1997) J. Clin. Invest. 100, 1847-1852[Medline] [Order article via Infotrieve]
9. Noguchi, C. T., and Schechter, A. N. (1981) Blood 58, 1057-1068[Free Full Text]
10. Ellory, J. C., Flatman, P. S., and Stewart, G. W. (1983) J. Physiol. (Lond.) 340, 1-17[Abstract/Free Full Text]
11. Brugnara, C. (1989) Ann. N. Y. Acad. Sci. 565, 96-103[CrossRef][Medline] [Order article via Infotrieve]
12. Scarpa, A. (1982) Tech. Cell. Physiol. 127, 1-40
13. Zhang, W., Truttmann, A. C., Luthi, D., and McGuigan, J. A. S. (1997) Anal. Biochem. 251, 246-250[CrossRef][Medline] [Order article via Infotrieve]
14. Rink, T. J., Tsien, R. Y., and Pozzan, T. (1982) J. Cell Biol. 95, 189-196[Abstract/Free Full Text]
15. Flatman, P. W., and Lew, V. L. (1977) Nature 267, 360-362[CrossRef][Medline] [Order article via Infotrieve]
16. Gupta, R. K., Benovic, J. L., and Rose, Z. B. (1978) J. Biol. Chem. 253, 6172-6176[Abstract/Free Full Text]
17. London, R. E. (1991) Annu. Rev. Physiol. 53, 241-258[Medline] [Order article via Infotrieve]
18. Geven, W. B., Vogels Mentink, G. M., Willems, J. L., von Os, C. H., Hilbers, C. W., Joordens, J. J., Rijksen, G., and Monnens, L. A. (1991) Clin. Chem. 37, 2076-2080[Abstract/Free Full Text]
19. Ouwerkerk, R., Van Echteld, C. J. A., Staal, G. E. J., and Rijksen, G. (1989) Biochim. Biophys. Acta 1010, 294-303[Medline] [Order article via Infotrieve]
20. Flatman, P. W. (1980) J. Physiol. (Lond.) 300, 19-30[Abstract/Free Full Text]
21. Moon, R. B., and Richards, J. H. (1973) J. Biol. Chem. 248, 7276-7278[Abstract/Free Full Text]
22. Lam, Y.-F., Allison, K., and Ho, C. (1979) Blood 54, 196-209[Abstract/Free Full Text]
23. Mulquiney, P. J., and Kuchel, P. W. (1997) NMR Biomed. 10, 129-137[CrossRef][Medline] [Order article via Infotrieve]
24. Tehrani, A. Y., Lam, Y.-F., Allison, K., and Ho, C. (1982) Blood Cells 8, 245-261[Medline] [Order article via Infotrieve]
25. Marjanovic, M., Gregory, C., Ghosh, P., Willis, J. S., and Dawson, M. J. (1993) J. Physiol. (Lond.) 470, 559-574[Abstract/Free Full Text]
26. Garfinkel, L., and Garfinkel, D. (1984) Biochemistry 23, 3547-3552[CrossRef][Medline] [Order article via Infotrieve]
27. Golding, E. M., and Golding, R. M. (1995) Mag. Reson. Med. 33, 467-474[Medline] [Order article via Infotrieve]
28. Goldberg, R. N., and Tewari, Y. B. (1991) Biochem. J. 40, 241-261
29. Mosher, T. J., Williams, G. D., Doumen, C., LaNoue, K. F., and Smith, M. B. (1992) Mag. Reson. Med. 24, 163-169[Medline] [Order article via Infotrieve]
30. Roberts, J. K., Wade-Jardetsky, N., and Jardetzky, O. (1981) Biochem. J. 20, 5389-5394
31. Williams, G. D., Mosher, T. J., and Smith, M. B. (1993) Anal. Biochem. 214, 458-467[CrossRef][Medline] [Order article via Infotrieve]
32. Willcocks, J. P., Veech, R. L., Ellory, J. C., Clarke, K., and Radda, G. K. (1999) Biophys. J. 76, 233[Medline] [Order article via Infotrieve] (abstr.)
33. Willcocks, J. P., Veech, R. L., Ellory, J. C., and Clarke, K. (2000) Biophys. J. 78, 449 (abstr.)
34. Clarke, K., Kashiwaya, Y., King, M. T., Gates, D., Keon, A., Cross, H. R., Radda, G. K., and Veech, R. L. (1996) J. Biol. Chem. 271, 21142-21150[Abstract/Free Full Text]
35. Veech, R. L., Gates, D. N., Crutchfield, C., Gitomer, W. L., Kashiwaya, Y., King, M. T., and Wondergem, R. (1994) Alcohol Clin. Exp. Res. 18, 1040-1056[CrossRef][Medline] [Order article via Infotrieve]
36. Berger, H., Janig, G.-R., Gerber, G., Ruckpaul, K., and Rapport, S. M. (1973) Eur. J. Biochem. 38, 553-562[Medline] [Order article via Infotrieve]
37. Mulquiney, P. J., and Kuchel, P. W. (1997) Eur. J. Biochem. 245, 71-83[Medline] [Order article via Infotrieve]
38. Werner, A., and Heinrich, R. (1985) Biomed. Biochim. Acta 44, 185-212[Medline] [Order article via Infotrieve]
39. Kaperonis, A. A., Bertles, J. F., and Chien, S. (1979) Br. J. Haematol. 43, 391-400[Medline] [Order article via Infotrieve]
40. Ortiz, O. E., Lew, V. L., and Bookchin, R. M. (1990) J. Physiol. (Lond.) 427, 211-226[Abstract/Free Full Text]
41. Corash, L. M., Piomelli, S., Chen, H. C., Seaman, C., and Gross, E. (1974) J. Lab. Clin. Med. 84, 147-151[Medline] [Order article via Infotrieve]
42. Ortiz, O. E., Lew, V. L., and Bookchin, R. M. (1986) Blood. 67, 710-715[Abstract/Free Full Text]
43. Jaeger, B. R., Goehring, P., Schirmer, J., Uhrig, S., Lohse, P., Kreuzer, E., Reichart, B., and Seidel, D. (2001) Ther. Apher. 5, 252-259[CrossRef][Medline] [Order article via Infotrieve]
44. Vasavada, K. V., Ray, B. D., and Nageswara Rao, B. D. (1984) J. Inorg. Biochem. 21, 323-335[CrossRef][Medline] [Order article via Infotrieve]
45. Ramirez, F., and Marecek, J. F. (1980) Biochim. Biophys. Acta 589, 21-29[Medline] [Order article via Infotrieve]
46. Pecoraro, V. L., Hermes, J. D., and Cleland, W. W. (1984) Biochem. J. 23, 5262-5271
47. Gupta, R. K., and Moore, R. D. (1980) J. Biol. Chem. 255, 3987-3993[Free Full Text]
48. Gupta, R. K., Gupta, P., Yushok, W. D., and Rose, Z. B. (1983) Physiol. Chem. Phys. Med. NMR 15, 265-280[Medline] [Order article via Infotrieve]
49. Raftos, J. E., Lew, V. L., and Flatman, P. W. (1999) Eur. J. Biochem. 263, 635-645[Medline] [Order article via Infotrieve]
50. Altura, B. M., Gebrewold, A., Altura, B. T., and Gupta, R. K. (1995) Alcohol 12, 131-136[CrossRef][Medline] [Order article via Infotrieve]
51. Gupta, R. K., Gupta, P., Yushok, W. D., and Rose, Z. B. (1983) Biochem. Biophys. Res. Commun. 117, 210-216[CrossRef][Medline] [Order article via Infotrieve]
52. Noguchi, C. T., Torchia, D. A., and Schechter, A. N. (1983) J. Clin. Invest. 72, 846-852[Medline] [Order article via Infotrieve]
53. De Franceschi, L., Bachir, D., Galacteros, F., Tchernia, G., Cynober, T., Neuberg, D., Beuzard, Y., and Brugnara, C. (2000) Br. J. Haematol. 108, 284-289[CrossRef][Medline] [Order article via Infotrieve]
54. Achilles, W., Cumme, G. A., and Hoppe, H. (1972) Acta Biol. Med. Ger. 29, 531-538[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
277/51/49911    most recent
M207551200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willcocks, J. P.
Right arrow Articles by Clarke, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willcocks, J. P.
Right arrow Articles by Clarke, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement